The design integration of wingtip devices for light general aviation aircraft

For abstract see A824093

Design Methodology for Multi-Element High-Lift Systems on Subsonic Civil Transport Aircraft

The choice of a high-lift system is crucial in the preliminary design process of a subsonic civil transport aircraft. Its purpose is to increase the allowable aircraft weight or decrease the aircraft's wing area for a given takeoff and landing performance. However, the implementation of a high-lift system into a design must be done carefully, for it can improve the aerodynamic performance of an aircraft but may also drastically increase the aircraft empty weight. If designed properly, a high-lift system can improve the cost effectiveness of an aircraft by increasing the payload weight for a given takeoff and landing performance. This is why the design methodology for a high-lift system should incorporate aerodynamic performance, weight, and cost. The airframe industry has experienced rapid technological growth in recent years which has led to significant advances in high-lift systems. For this reason many existing design methodologies have become obsolete since they are based on outdated low Reynolds number wind-tunnel data and can no longer accurately predict the aerodynamic characteristics or weight of current multi-element wings. Therefore, a new design methodology has been created that reflects current aerodynamic, weight, and cost data and provides enough flexibility to allow incorporation of new data when it becomes available

Support Vector Machine untuk Klasifikasi Penutup Lahan Menggunakan Citra Radarsat 2 dengan Dual Polarisasi Hh-hv

Radarsat 2 citra. satelit yang memiliki spesifikasi baru dan lebih baik dari generasi tua dengan resolusi spasial tinggi. Radarsat 2 dapat digunakan untuk klasifikasi tutupan lahan dengan mesin vektor Dukungan algoritma bahwa mesin pembelajaran algoritma yang akan menjadi alternatif kecuali kemungkinan maksimum bahkan algoritma yang tidak dapat digunakan untuk dual polarisasi HH-HV yang SVM bisa mengatasinya. Support Vector Machine algoritma dapat memberikan informasi tutupan lahan otomatis yang dapat mengembangkan metode aplikasi untuk monitoring tutupan lahan untuk negara tropis seperti Indonesia. Metode yang kami gunakan untuk mengumpulkan Region of Interest dan uji validasi oleh survei lapangan. Penelitian ini menggunakan smartphone GPS android dengan 120 tempat sampel dengan perhitungan error 6,5%. Setelah itu kita menguji akurasi dengan meja kebingungan matriks. Hasil tutupan lahan klasifikasi menunjukkan bahwa klasifikasi keseluruhan adalah 66,67% dan memiliki koefisien kappa sebagai 0,55821446 yang menunjukkan hasil mengindikasikan tidak sesuai dengan

Viscous-flow analysis of a subsonic transport aircraft high-lift system and correlation with flight data

High-lift system aerodynamics has been gaining attention in recent years. In an effort to improve aircraft performance, comprehensive studies of multi-element airfoil systems are being undertaken in wind-tunnel and flight experiments. Recent developments in Computational Fluid Dynamics (CFD) offer a relatively inexpensive alternative for studying complex viscous flows by numerically solving the Navier-Stokes (N-S) equations. Current limitations in computer resources restrict practical high-lift N-S computations to two dimensions, but CFD predictions can yield tremendous insight into flow structure, interactions between airfoil elements, and effects of changes in airfoil geometry or free-stream conditions. These codes are very accurate when compared to strictly 2D data provided by wind-tunnel testing, as will be shown here. Yet, additional challenges must be faced in the analysis of a production aircraft wing section, such as that of the NASA Langley Transport Systems Research Vehicle (TSRV). A primary issue is the sweep theory used to correlate 2D predictions with 3D flight results, accounting for sweep, taper, and finite wing effects. Other computational issues addressed here include the effects of surface roughness of the geometry, cove shape modeling, grid topology, and transition specification. The sensitivity of the flow to changing free-stream conditions is investigated. In addition, the effects of Gurney flaps on the aerodynamic characteristics of the airfoil system are predicted

Support Vector Machine untuk Klasifikasi Penutup Lahan Menggunakan Citra Radarsat 2 dengan Dual Polarisasi Hh-hv

Radarsat 2 citra. satelit yang memiliki spesifikasi baru dan lebih baik dari generasi tua dengan resolusi spasial tinggi. Radarsat 2 dapat digunakan untuk klasifikasi tutupan lahan dengan mesin vektor Dukungan algoritma bahwa mesin pembelajaran algoritma yang akan menjadi alternatif kecuali kemungkinan maksimum bahkan algoritma yang tidak dapat digunakan untuk dual polarisasi HH-HV yang SVM bisa mengatasinya. Support Vector Machine algoritma dapat memberikan informasi tutupan lahan otomatis yang dapat mengembangkan metode aplikasi untuk monitoring tutupan lahan untuk negara tropis seperti Indonesia. Metode yang kami gunakan untuk mengumpulkan Region of Interest dan uji validasi oleh survei lapangan. Penelitian ini menggunakan smartphone GPS android dengan 120 tempat sampel dengan perhitungan error 6,5%. Setelah itu kita menguji akurasi dengan meja kebingungan matriks. Hasil tutupan lahan klasifikasi menunjukkan bahwa klasifikasi keseluruhan adalah 66,67% dan memiliki koefisien kappa sebagai 0,55821446 yang menunjukkan hasil mengindikasikan tidak sesuai dengan

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

Targeted cancer therapy requires the rapid and accurate identification of genetic abnormalities predictive of therapeutic response. We sought to develop a high-throughput genotyping platform that would allow prospective patient selection to the best available therapies, and that could readily and inexpensively be adopted by most clinical laboratories. We developed a highly sensitive multiplexed clinical assay that performs very well with nucleic acid derived from formalin fixation and paraffin embedding (FFPE) tissue, and tests for 120 previously described mutations in 13 cancer genes. Genetic profiling of 250 primary tumours was consistent with the documented oncogene mutational spectrum and identified rare events in some cancer types. The assay is currently being used for clinical testing of tumour samples and contributing to cancer patient management. This work therefore establishes a platform for real-time targeted genotyping that can be widely adopted. We expect that efforts like this one will play an increasingly important role in cancer management

Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease

Beta-amyloid (Aβ) peptides are considered to play a major role in the pathogenesis of Alzheimer's disease (AD) and molecules that can prevent pathways of Aβ toxicity may be potential therapeutic agents for treatment of AD. We have previously reported that NK-4, a cyanine photosensitizing dye, displays neurotrophic and antioxidant activities. In this study, we report the effects of NK-4 on the toxicity of Aβ and on cognitive function and Aβ concentration in a transgenic mouse model of AD (Tg2576). In vitro, NK-4 effectively protected neuronal cells from toxicity induced by Aβ. In addition, it displayed profound inhibitory activities on Aβ fibril formation. In vivo, Tg2576 mice received an intraperitoneal injection at 100 or 500 µg/kg of NK-4 once a day, five times a week for 9 months. Administration of NK-4 to the mice attenuated impairment of recognition memory, associative memory, and learning ability, as assessed by a novel object recognition test, a passive avoidance test, and a water maze test, respectively. NK-4 decreased the brain Aβ concentration while increasing the plasma amyloid level in a dose-dependent manner. NK-4 also improved memory impairments of ICR mice induced by direct intracerebroventricular administration of Aβ. These lines of evidence suggest that NK-4 may affect multiple pathways of amyloid pathogenesis and could be useful for treatment of AD

Parental origin of sequence variants associated with complex diseases

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldEffects of susceptibility variants may depend on from which parent they are inherited. Although many associations between sequence variants and human traits have been discovered through genome-wide associations, the impact of parental origin has largely been ignored. Here we show that for 38,167 Icelanders genotyped using single nucleotide polymorphism (SNP) chips, the parental origin of most alleles can be determined. For this we used a combination of genealogy and long-range phasing. We then focused on SNPs that associate with diseases and are within 500 kilobases of known imprinted genes. Seven independent SNP associations were examined. Five-one with breast cancer, one with basal-cell carcinoma and three with type 2 diabetes-have parental-origin-specific associations. These variants are located in two genomic regions, 11p15 and 7q32, each harbouring a cluster of imprinted genes. Furthermore, we observed a novel association between the SNP rs2334499 at 11p15 and type 2 diabetes. Here the allele that confers risk when paternally inherited is protective when maternally transmitted. We identified a differentially methylated CTCF-binding site at 11p15 and demonstrated correlation of rs2334499 with decreased methylation of that site.info:eu-repo/grantAgreement/EC/FP7/21807

Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

Glioblastoma (GBM) is a highly aggressive brain cancer characterized by local invasion and angiogenic recruitment, yet metastatic dissemination is extremely rare. Here, we adapted a microfluidic device to deplete hematopoietic cells from blood specimens of patients with GBM, uncovering evidence of circulating brain tumor cells (CTCs). Staining and scoring criteria for GBM CTCs were first established using orthotopic patient-derived xenografts (PDX), and then applied clinically: CTCs were identified in at least one blood specimen from 13/33 patients (39%; 26/87 samples). Single GBM CTCs isolated from both patients and mouse PDX models demonstrated enrichment for mesenchymal over neural differentiation markers, compared with primary GBMs. Within primary GBMs, RNA-in-situ hybridization identifies a subpopulation of highly migratory mesenchymal tumor cells, and in a rare patient with disseminated GBM, systemic lesions were exclusively mesenchymal. Thus, a mesenchymal subset of GBM cells invades into the vasculature, and may proliferate outside the brain

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.